HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

State Enforcement Needed On Weight Loss, Bodybuilding Supplements – Study

This article was originally published in The Tan Sheet

Executive Summary

“The lax federal regulatory scheme for dietary supplements leaves extreme gaps in federal oversight that should be filled by state governments,” according to a report by public health experts. State attorneys general have “bully pulpit” to expand on enforcement authorities exercised by both FDA and FTC, they say.

You may also be interested in...



Expand Federal Pre-emption In Supplement Claims Complaints? Not So Fast, Says Ninth Circuit

The ruling reverses district court’s dismissal of class action against CVS after determining the lower court erred in determining federal law pre-empted the consumer plaintiff’s state-law causes of action. It says while consumers are prohibited under California law from arguing that a product doesn’t provide a benefit that isn’t claimed, plaintiffs can demand substantiation for claims that are made.

N.Y. Supplement Marketing Restriction Bill Raises Specter Of Copycats

Stakeholders fear legislation proposed in New York to restrict sports supplement sales to consumers 18 and older and to require additional labeling could inspire copy-cats in other states. Trade groups say DSHEA already covers the proposed legislation’s goals.

FDA Ushers Out Known DMAA, Closes Dietary Ingredient Door

USPlabs says it will reformulate its DMAA supplements, although it “stands by the safety and legality” of the products. FDA says “credible science” shows DMAA is not a botanical, not a dietary ingredient and will not be accepted in an NDI notification.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS139641

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel